Old Web
English
Sign In
Acemap
>
Paper
>
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
2016
Hong Wu
Chen Hu
Aoli Wang
Ellen Weisberg
Wenchao Wang
Cheng Chen
Zheng Zhao
Kailin Yu
Jing Liu
Jiaxin Wu
Atsushi Nonami
Li Wang
Beilei Wang
Richard Stone
Suiyang Liu
James D. Griffin
Qingsong Liu
Keywords:
Cancer research
Immunology
Mutant
Biology
Ibrutinib
flt3 itd
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
18
References
23
Citations
NaN
KQI
[]